{
  "items": [
    {
      "title": "AMGEN - POSITIVE RESULTS FROM TEZSPIRE PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS",
      "description": "THOUSAND OAKS - Amgen and AstraZeneca today announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE significantly reduced nasal polyp severity, the need...",
      "published_utc": "2025-03-03T18:59:21",
      "source": "Finnhub",
      "url": "https://finnhub.io/api/news?id=0b3cba3af4c73ad515039f3b29a898f7da41832d0ff9060bda05446e9c88d6f4",
      "category": "company",
      "image": "",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 132954284,
      "datetime": 1740999561
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T07:13:24.697373+00:00",
    "cache_key": "news_b2a456860943da6e2b2dc71c661fdb20",
    "count": 1
  }
}